Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

174
Delayed Quote. Delayed London Stock Exchange - 01/27 07:09:11 am
1501.125 GBp   +0.18%
04:13a Novartis flags faster sales and profit growth for 2015
03:02aDJNovartis Upbeat Despite Weaker Profit -- Update
01/26DJU.S. to Give $1 Billion to Fund Immunizations -- 2nd Update
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

05/03/2012 | 02:11pm US/Eastern

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
React to this article
Latest news on GLAXOSMITHKLINE PLC
04:13a Novartis flags faster sales and profit growth for 2015
03:02aDJNovartis Upbeat Despite Weaker Profit -- Update
01/26DJU.S. to Give $1 Billion to Fund Immunizations -- 2nd Update
01/26 GLAXOSMITHKLINE : Major milestone for GSK/NIH candidate Ebola vaccine as first d..
01/26 GLAXOSMITHKLINE : Glaxo Expands Portfolio Of Medicines In US To Treat Asthma And..
01/23 Mylan Launches Generic Epivir-HBV® Tablets
01/23 GLAXOSMITHKLINE : First experimental Ebola vaccine to arrive in Liberia
01/23 GLAXOSMITHKLINE : Ebola crisis: Experimental vaccine ‘shipped to Liberia&r..
01/23 GLAXOSMITHKLINE : Ships Batch Of Ebola Vaccine To West Africa For Trials
01/23 GLAXOSMITHKLINE : GSK ‘confronts COPD’ to deliver new insights from ..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF